Journals / Turkish Journal of Gastroenterology / 2022 / Cilt: 33 - Sayı: 2

Coronavirus Precautions: Experience of High Volume Liver Transplant Institute

Pages
145–152
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Healthcare workers have shown tremendous effort and are the true heroes of this era.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: To present the struggle of a high volume liver transplant center against coronavirus infectious disease-2019 pandemic.
📊
Key Findings & Data:Methods: Between March 2020 and December 2020, the demographic and clinical data of staff and liver transplant candidates diagnosed with coronavirus infectious disease-2019 in our Liver Transplant Institute were prospectively analyzed.
💡
Conclusion & Impact:Healthcare workers have shown tremendous effort and are the true heroes of this era.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Background: To present the struggle of a high volume liver transplant center against coronavirus infectious disease-2019 pandemic. Methods: Between March 2020 and December 2020, the demographic and clinical data of staff and liver transplant candidates diagnosed with coronavirus infectious disease-2019 in our Liver Transplant Institute were prospectively analyzed. Results: First, 32 healthcare staff were diagnosed with coronavirus infectious disease-2019, and 6 of them were surgeons. Six staff were asymptomatic, while 24 staff had mild or moderate and 2 staff had severe coronavirus infectious disease-2019. All the staff recovered from the disease without any permanent sequela and returned to duty after 2 consecutive negative polymerase chain reaction results within 24-hour intervals. Second, during the preoperative investigation, 6 living liver donor candidates and 13 recipients were tested positive for coronavirus infectious disease-2019 (son = 6, unrelated = 3, cousin = 3, daughter = 2, cadaveric = 1). Eleven patients received favipiravir and 8 did not receive any treatment because they were asymptomatic. Only one recipient who had severe coronavirus infectious disease-2019 died due to multiple organ failure syndrome. One recipient died in the early postoperative period. The median duration from the initial diagnosis of the patients till the transplant procedure was 21 days (min-max: 14-105 days). During the time of operation, the polymerase chain reaction tests of the donors and the recipients were negative, and the thorax tomography images showed no signs of viral pneumonia. Conclusion: Meticulous precautions, multidisciplinary approach, team effort, and organization of facilities can increase the quality of care of these patients in the coronavirus infectious disease-2019 era. Healthcare workers have shown tremendous effort and are the true heroes of this era.

🔖

Cite This Article

BAŞKIRAN, A., AKBULUT, A. S., ŞAHİN, T. T., YILMAZ, S., TUNCER, A., KAPLAN, K., BAYINDIR, Y. (2022). Coronavirus Precautions: Experience of High Volume Liver Transplant Institute. Turkish Journal of Gastroenterology, Cilt: 33 - Sayı: 2, 145–152. https://ajindex.com/articles/417308

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Da Costa VG, Moreli ML, Saivish MV. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Arch Virol. 2020
  2. 165(7):1517-1526. [CrossRef] 2. Fauci AS, Lane HC, Redfield RR. COVID-19 - navigating the uncharted. N Engl J Med. 2020
  3. 382(13):1268-1269. [CrossRef] 3. Hua J, Shaw R. Corona virus (COVID-19) “Infodemic” and emerging issues through a data lens: the case of China. Int J Environ Res Public Health. 2020
  4. 17(7):2309. [CrossRef] 4. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020
  5. 382(13):1199-1207. [CrossRef] 5. Meriç S, Aktokmakyan TV, Tokocin M, Aktimur YE, Hacım NA, Gülcicek OB. Comparative analysis of the management of acute appendicitis between the normal period and COVID-19 pandemic. Ulus Travma Acil Cerrahi Derg. 2021
  6. 27(1):22-25. [CrossRef] 6. Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020
  7. 4(5):e10-e11. [CrossRef] 7. Chudasama YV, Gillies CL, Zaccardi F, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020
  8. 14(5):965- 967. [CrossRef] 8. Viganò M, Carbone M. Let’s not forget our COVID-19-free cirrhotic patients! Liver Int. 2020
  9. 40(6):1508-1509. [CrossRef] 9. Sahin TT, Akbulut S, Yilmaz S. COVID-19 pandemic: its impact on liver disease and liver transplantation. World J Gastroenterol. 2020
  10. 26(22):2987-2999. [CrossRef] 10. Dirican A, Baskiran A, Dogan M, et al. Evaluation of potential donors in living donor liver transplantation. Transplant Proc. 2015
  11. 47(5):1315-1318. [CrossRef] 11. T.C. Sağlık Bakanlığı. COVID-19 Bilgilendirme Platformu. 2021. Available at: https://covid19.saglik.gov.tr. 12. Herron JBT, Hay-David AGC, Gilliam AD, Brennan PA. Personal protective equipment and COVID 19: a risk to healthcare staff? Br J Oral Maxillofac Surg. 2020
  12. 58(5):500-502. [CrossRef] 13. Fix OK, Hameed B, Fontana RJ, et al. Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Hepatology. 2020
  13. 72(1):287-304. [CrossRef] 14. Michaels MG, La Hoz RM, Danziger-Isakov L, et al. Coronavirus disease 2019: implications of emerging infections for transplantation. Am J Transplant. 2020
  14. 20(7):1768-1772. [CrossRef] 15. Qin J, Wang H, Qin X, et al. Periope